Literature DB >> 31325229

Education, Home Exercise, and Supervised Exercise for People With Hip and Knee Osteoarthritis As Part of a Nationwide Implementation Program: Data From the Better Management of Patients With Osteoarthritis Registry.

Andrea Dell'Isola1, Thérése Jönsson2, Jonas Ranstam1, Leif E Dahlberg1, Eva Ekvall Hansson1.   

Abstract

OBJECTIVE: To compare the effectiveness of education (ED) plus home exercise (HE) and ED plus supervised exercise (SE) according to information provided by the Better Management of Patients With Osteoarthritis (BOA) Registry, a nationally implemented rehabilitation program for patients with hip and knee osteoarthritis (OA). In addition, we investigated whether or not the effect of the treatments differed based on the joint affected by OA (hip versus knee).
METHODS: We included 38,030 participants from the BOA Registry with knee or hip OA who were treated with either ED, HE, or SE. The effect of the 3 treatment options on the pain intensity reduction (range 0-10) immediately postintervention and at 12 months was estimated using a mixed-effects model adjusted for age, sex, body mass index, affected joint (hip or knee), pain at baseline, comorbidity, and level of education.
RESULTS: The participants undergoing HE or SE experienced a greater pain reduction compared to participants who received ED, both after the treatment (group mean change for ED -0.91 [95% confidence interval (95% CI) -1.15, -0.68], for HE -1.06 [95% CI -1.10, -1.01], and for SE -1.12 [95% CI -1.15, -1.08]) and at 12 months (group mean change for ED -0.58 [95% CI -0.87, -0.30], for HE -0.82 [95% CI -0.87, -0.76], and for SE -0.82 [95% CI -0.86, -0.77]). Patients with knee OA who underwent HE or SE improved more compared to patients with hip OA at both follow-ups.
CONCLUSION: In primary care, HE and SE lead to similar reductions in pain intensity but are more effective than ED alone. In addition, people with knee OA benefit more from HE and SE than people with hip OA.
© 2019, American College of Rheumatology.

Entities:  

Mesh:

Year:  2020        PMID: 31325229     DOI: 10.1002/acr.24033

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  6 in total

1.  Physical activity patterns, adherence to using a wearable activity tracker during a 12-week period and correlation between self-reported function and physical activity in working age individuals with hip and/or knee osteoarthritis.

Authors:  Elin Östlind; Anita Sant'Anna; Frida Eek; Kjerstin Stigmar; Eva Ekvall Hansson
Journal:  BMC Musculoskelet Disord       Date:  2021-05-15       Impact factor: 2.362

2.  Improving osteoarthritis care by digital means - Effects of a digital self-management program after 24- or 48-weeks of treatment.

Authors:  Leif E Dahlberg; Andrea Dell'Isola; L Stefan Lohmander; Håkan Nero
Journal:  PLoS One       Date:  2020-03-04       Impact factor: 3.240

3.  Factors Associated With the Outcome of a First-Line Intervention for Patients With Hip or Knee Osteoarthritis or Both: Data From the BOA Register.

Authors:  Andrea Dell'Isola; Therese Jönsson; Håkan Nero; Frida Eek; Leif Dahlberg
Journal:  Phys Ther       Date:  2020-09-28

4.  T2 mapping for knee cartilage degeneration in young patients with mild symptoms.

Authors:  Huiyu Zhao; Hongqiu Li; Shuo Liang; Xinyue Wang; Feng Yang
Journal:  BMC Med Imaging       Date:  2022-04-18       Impact factor: 2.795

5.  Digital Care Programs for Chronic Hip Pain: A Prospective Longitudinal Cohort Study.

Authors:  Dora Janela; Fabíola Costa; Anabela C Areias; Maria Molinos; Robert G Moulder; Jorge Lains; Virgílio Bento; Justin K Scheer; Vijay Yanamadala; Steven P Cohen; Fernando Dias Correia
Journal:  Healthcare (Basel)       Date:  2022-08-22

6.  Willingness to Undergo Joint Surgery Following a First-Line Intervention for Osteoarthritis: Data From the Better Management of People With Osteoarthritis Register.

Authors:  Andrea Dell'Isola; Thèrèse Jönsson; Ola Rolfson; Anna Cronström; Martin Englund; Leif Dahlberg
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-06       Impact factor: 4.794

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.